2H

2Pharma Holding

BE0644.751.377

Gross margin
€ -2K ↑ 34% 2025 Total € 24K
Profit
€ -3K ↑ 7% 2025 Total € -27K
EBITDA
€ -3K ↑ 22% 2025 Total € 23K
EBIT
€ -3K ↑ 22% 2025 Total € 23K
Net profit
€ -3K ↑ 7% 2025 Total € -27K
Assets
€ 1.87M ↓ 2% 2025
Equity
€ 34K ↓ 9% 2025
Debt
€ 1.83M ↓ 2% 2025
Cash
€ 48K ↓ 92% 2022
Cashflow
€ -3K ↑ 7% 2025 Total € -27K
Working capital
€ -1.83M 2025
Current ratio
0.00 ↓ 100% 2025
Quick ratio
0.00 ↓ 100% 2025
Working capital ratio
0.00 ↓ 100% 2025
Debt
€ 1.83M ↓ 2% 2025
Short-term debt
€ 1.83M ↓ 2% 2025
Long-term debt
€ 1.01M ↓ 6% 2018
Debt / EBITDA
62.89 ↑ 12% 2018
Solvability
1.9% ↓ 0.1 pt 2025
Long term debt ratio
10.83 ↓ 21% 2018
Interest Coverage Ratio
2.13 2016
Gross profitability
-9.3% ↓ 0.1 pt 2025
Net profitability
-9.3% ↓ 0.1 pt 2025
Return On Assets (ROA)
-0.17 ↑ 6% 2025
Return On Equity (ROE)
-9.30 ↓ 1% 2025
Customer credit
176 2016
Days Sales Outstanding (DSO)
176 2016
Taxes
€ 1K ↓ 6% 2019 Total € 12K